Literature DB >> 23661421

Dysregulating IRES-dependent translation contributes to overexpression of oncogenic Aurora A Kinase.

Tara Dobson1, Juan Chen, Les A Krushel.   

Abstract

UNLABELLED: Overexpression of the oncoprotein Aurora A kinase occurs in multiple types of cancer, often early during cell transformation. To identify the mechanism(s) contributing to enhanced Aurora A protein expression, a comparison between normal human lung fibroblast and breast epithelial cells to nontumorigenic breast (MCF10A and MCF12A) and tumorigenic breast (MCF-7) and cervical cell lines (HeLa S3) was performed. A subset of these immortalized lines (MCF10A, MCF12A, and HeLa S3) exhibited increased levels of Aurora A protein, independent of tumorigenicity. The increase in Aurora A protein in these immortalized cells was not due to increased transcription/RNA stability, protein half-life, or cap-dependent translation. Assays utilizing monocistronic and dicistronic RNA constructs revealed that the 5'-leader sequence of Aurora A contains an internal ribosomal entry site (IRES), which is regulated in a cell cycle-dependent manner, peaking in G2/M phase. Moreover, IRES activity was increased in the immortalized cell lines in which Aurora A protein expression was also enhanced. Additional studies indicated that the increased internal initiation is specific to the IRES of Aurora A and may be an early event during cancer progression. These results identify a novel mechanism contributing to Aurora A kinase overexpression. IMPLICATIONS: The current study indicates that Aurora A kinase contributes to immortalization and tumorigenesis. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661421      PMCID: PMC4109694          DOI: 10.1158/1541-7786.MCR-12-0707

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  94 in total

1.  Identification and characterization of a novel cell cycle-regulated internal ribosome entry site.

Authors:  S Cornelis; Y Bruynooghe; G Denecker; S Van Huffel; S Tinton; R Beyaert
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  The chicken c-Jun 5' untranslated region directs translation by internal initiation.

Authors:  A Sehgal; J Briggs; J Rinehart-Kim; J Basso; T J Bos
Journal:  Oncogene       Date:  2000-06-01       Impact factor: 9.867

3.  A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.

Authors:  S Sen; H Zhou; R A White
Journal:  Oncogene       Date:  1997-05-08       Impact factor: 9.867

4.  Regulation of protein synthesis in chick oviduct. I. Independent regulation of ovalbumin, conalbumin, ovomucoid, and lysozyme induction.

Authors:  R D Palmiter
Journal:  J Biol Chem       Date:  1972-10-25       Impact factor: 5.157

5.  Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.

Authors:  Andrew Yoon; Guang Peng; Yves Brandenburger; Yves Brandenburg; Ornella Zollo; Wei Xu; Eduardo Rego; Davide Ruggero
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

6.  The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation.

Authors:  N Ali; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis.

Authors:  Thea M Goepfert; Yetunde E Adigun; Ling Zhong; Jason Gay; Daniel Medina; William R Brinkley
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

8.  Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F.

Authors:  R Duncan; S C Milburn; J W Hershey
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

9.  Pyrimidine tract binding protein strongly stimulates in vitro encephalomyocarditis virus RNA translation at the level of preinitiation complex formation.

Authors:  A Borovjagin; T Pestova; I Shatsky
Journal:  FEBS Lett       Date:  1994-09-12       Impact factor: 4.124

Review 10.  Aurora kinase inhibitors.

Authors:  J J E M Kitzen; M J A de Jonge; J Verweij
Journal:  Crit Rev Oncol Hematol       Date:  2009-04-14       Impact factor: 6.312

View more
  11 in total

Review 1.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

Review 2.  A researcher's guide to the galaxy of IRESs.

Authors:  Ilya M Terenin; Victoria V Smirnova; Dmitri E Andreev; Sergey E Dmitriev; Ivan N Shatsky
Journal:  Cell Mol Life Sci       Date:  2016-11-16       Impact factor: 9.207

3.  Small molecule inhibitors of IRES-mediated translation.

Authors:  Christos Vaklavas; Zheng Meng; Hyoungsoo Choi; William E Grizzle; Kurt R Zinn; Scott W Blume
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

Review 4.  Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.

Authors:  Christos Vaklavas; Scott W Blume; William E Grizzle
Journal:  Front Oncol       Date:  2017-07-26       Impact factor: 6.244

5.  Translational upregulation of Aurora-A by hnRNP Q1 contributes to cell proliferation and tumorigenesis in colorectal cancer.

Authors:  Chien-Hsien Lai; Yu-Chuan Huang; Jenq-Chang Lee; Joseph Ta-Chien Tseng; Kung-Chao Chang; Yen-Ju Chen; Nai-Jhu Ding; Pao-Hsuan Huang; Wen-Chang Chang; Bo-Wen Lin; Ruo-Yu Chen; Yu-Chu Wang; Yi-Chien Lai; Liang-Yi Hung
Journal:  Cell Death Dis       Date:  2017-01-12       Impact factor: 8.469

6.  IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens.

Authors:  Maud Charpentier; Mikael Croyal; Delphine Carbonnelle; Agnès Fortun; Laetitia Florenceau; Catherine Rabu; Michel Krempf; Nathalie Labarrière; François Lang
Journal:  Oncotarget       Date:  2016-09-13

7.  Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition.

Authors:  Christos Vaklavas; Kurt R Zinn; Sharon L Samuel; Zheng Meng; William E Grizzle; Hyoungsoo Choi; Scott W Blume
Journal:  Oncol Rep       Date:  2018-03-23       Impact factor: 3.906

8.  Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors.

Authors:  Quincy Siu-Chung Chu; Nathaniel Bouganim; Caroline Fortier; Sara Zaknoen; John R Stille; Jill D Kremer; Eunice Yuen; Yu-Hua Hui; Amparo de la Peña; Andrew Lithio; Patricia S Smith; Gerald Batist
Journal:  Invest New Drugs       Date:  2021-01-22       Impact factor: 3.651

Review 9.  The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy.

Authors:  Jimin Yuan; Xiaoduo Dong; Jiajun Yap; Jiancheng Hu
Journal:  J Hematol Oncol       Date:  2020-08-17       Impact factor: 17.388

10.  The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.

Authors:  D Larrieu; M Brunet; C Vargas; N Hanoun; L Ligat; L Dagnon; H Lulka; R M Pommier; J Selves; B E Jády; L Bartholin; P Cordelier; M Dufresne; J Torrisani
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.